UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 801

Sortiert nach

What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?

Journal of Chromatography A, 2013-05, Vol.1292, p.19-24

Maurer, Hans H.

2013

Link zum Volltext

Verfügbarkeit prüfen

Refined protocols of tamoxifen injection for inducible DNA recombination in mouse astroglia

Scientific reports, 2018-04, Vol.8 (1), p.5913-11, Article 5913

2018

Link zum Volltext

Verfügbarkeit prüfen

Orbitrap technology for comprehensive metabolite-based liquid chromatographic–high resolution-tandem mass spectrometric urine drug screening – Exemplified for cardiovascular drugs

Analytica chimica acta, 2015-09, Vol.891, p.221-233

2015

Link zum Volltext

Verfügbarkeit prüfen

Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples

Journal of pharmaceutical and biomedical analysis, 2017-09, Vol.143, p.32-42

2017

Link zum Volltext

Verfügbarkeit prüfen

Metabolism of designer drugs of abuse: an updated review

Current drug metabolism, 2010-06, Vol.11 (5), p.468

2010

Link zum Volltext

Verfügbarkeit prüfen

Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry

Analytical and bioanalytical chemistry, 2010-06, Vol.397 (3), p.1225-1233

2010

Link zum Volltext

Verfügbarkeit prüfen

Chemistry, pharmacology, and metabolism of emerging drugs of abuse

Therapeutic drug monitoring, 2010-10, Vol.32 (5), p.544

Maurer, Hans H

2010

Link zum Volltext

Verfügbarkeit prüfen

What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse?

Toxicology letters, 2016-09, Vol.258, p.55-70

2016

Link zum Volltext

Verfügbarkeit prüfen

Chiral drug analysis using mass spectrometric detection relevant to research and practice in clinical and forensic toxicology

Journal of Chromatography A, 2012-12, Vol.1269, p.122-135

2012

Link zum Volltext

Verfügbarkeit prüfen

Development of a quantitative approach in blood plasma for low-dosed hallucinogens and opioids using LC-high resolution mass spectrometry

Talanta (Oxford), 2018-01, Vol.176, p.635-645

2018

Link zum Volltext

Verfügbarkeit prüfen

Hyphenated high-resolution mass spectrometry—the “all-in-one” device in analytical toxicology?

Analytical and bioanalytical chemistry, 2021-04, Vol.413 (9), p.2303-2309

Maurer, Hans H.

2021

Link zum Volltext

Verfügbarkeit prüfen

Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept

Analytical and bioanalytical chemistry, 2011-07, Vol.400 (10), p.3481-3489

2011

Link zum Volltext

Verfügbarkeit prüfen

New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”

Current neuropharmacology, 2017-07, Vol.15 (5), p.692-712

2017

Link zum Volltext

Verfügbarkeit prüfen

Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology

Clinical biochemistry, 2005-04, Vol.38 (4), p.310-318

Maurer, Hans H.

2005

Link zum Volltext

Verfügbarkeit prüfen

Mass spectrometric approaches in impaired driving toxicology

Analytical and bioanalytical chemistry, 2009-01, Vol.393 (1), p.97-107

Maurer, Hans H

2009

Link zum Volltext

Verfügbarkeit prüfen

Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach

Analytical and bioanalytical chemistry, 2014-01, Vol.406 (3), p.803-818

2014

Link zum Volltext

Verfügbarkeit prüfen

The in Vivo TRPV6 Protein Starts at a Non-AUG Triplet, Decoded as Methionine, Upstream of Canonical Initiation at AUG

The Journal of biological chemistry, 2013-06, Vol.288 (23), p.16629-16644

2013

Link zum Volltext

Verfügbarkeit prüfen

New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology

1st ed. 2018., 2019

Link zum Volltext

Verfügbarkeit prüfen

Biofilm inhibition by an experimental dental resin composite containing octenidine dihydrochloride

Dental materials, 2012-09, Vol.28 (9), p.974-984

2012

Link zum Volltext

Verfügbarkeit prüfen

Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology

Analytical and bioanalytical chemistry, 2007-08, Vol.388 (7), p.1315-1325

Maurer, Hans H

2007

Link zum Volltext

Verfügbarkeit prüfen

The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers

Drug metabolism and disposition, 2008-11, Vol.36 (11), p.2345

2008

Link zum Volltext

Verfügbarkeit prüfen

Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control

Clinical chemistry and laboratory medicine, 2004-01, Vol.42 (11), p.1310-1324

Maurer, Hans H.

2004

Link zum Volltext

Verfügbarkeit prüfen

Quantification of 33 antidepressants by LC-MS/MS—comparative validation in whole blood, plasma, and serum

Analytical and bioanalytical chemistry, 2014-09, Vol.406 (24), p.5939-5953

2014

Link zum Volltext

Verfügbarkeit prüfen

Mass Spectrometry for Research and Application in Therapeutic Drug Monitoring or Clinical and Forensic Toxicology

Therapeutic drug monitoring, 2018-08, Vol.40 (4), p.389

Maurer, Hans H

2018

Link zum Volltext

Verfügbarkeit prüfen

Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs

Current neuropharmacology, 2017-01, Vol.15 (5), p.713-723

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 801

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(633)
Mit Volltextzugriff
(701)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(463)
Life Sciences & Biomedicine
(407)
Humans
(307)
Chemistry
(193)
Biological And Medical Sciences
(185)
Physical Sciences
(183)
Medical Sciences
(160)
Chemistry, Analytical
(159)
Biochemistry & Molecular Biology
(153)
Animals
(152)
Male
(144)
Toxicology
(138)
Biochemical Research Methods
(130)
Metabolism
(106)
Pharmacology & Pharmacy
(105)
Rats
(99)
Mass Spectrometry
(98)
Gas Chromatography-Mass Spectrometry - Methods
(79)
Pharmacology. Drug Treatments
(78)
Metabolites
(73)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?

Refined protocols of tamoxifen injection for inducible DNA recombination in mouse astroglia

Orbitrap technology for comprehensive metabolite-based liquid chromatographic–high resolution-tandem mass spectrometric urine drug screening – Exemplified for cardiovascular drugs

Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples

Metabolism of designer drugs of abuse: an updated review

Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry

Chemistry, pharmacology, and metabolism of emerging drugs of abuse

What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse?

Chiral drug analysis using mass spectrometric detection relevant to research and practice in clinical and forensic toxicology

Development of a quantitative approach in blood plasma for low-dosed hallucinogens and opioids using LC-high resolution mass spectrometry

Hyphenated high-resolution mass spectrometry—the “all-in-one” device in analytical toxicology?

Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept

New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”

Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology

Mass spectrometric approaches in impaired driving toxicology

Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach

The in Vivo TRPV6 Protein Starts at a Non-AUG Triplet, Decoded as Methionine, Upstream of Canonical Initiation at AUG

New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology

Biofilm inhibition by an experimental dental resin composite containing octenidine dihydrochloride

Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology

The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers

Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control

Quantification of 33 antidepressants by LC-MS/MS—comparative validation in whole blood, plasma, and serum

Mass Spectrometry for Research and Application in Therapeutic Drug Monitoring or Clinical and Forensic Toxicology

Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs

Suchergebnisse filtern